While both ETFs target the high-flying U.S. technology sector, a closer look reveals critical distinctions in diversification, concentration risk, and liquidity that could sway long-term portfolio outcomes.
The Biden administration has approved a major arms sale to Israel, featuring attack helicopters and armored vehicles, amid a fragile ceasefire in Gaza and ongoing scrutiny over U.S. military support.
A key ally of Prime Minister Narendra Modi has proposed legislation to prohibit social media access for children under 16, framing the move as a response to digital addiction and the exploitation of Indian user data by foreign tech giants, amid a growing global regulatory push.
Inditex (BME:ITX) shares have taken a breather, trading flat over the past week after a robust multi-year performance. With the stock slightly below analyst targets, investors are weighing whether the current price offers value or if the growth momentum is cooling.
Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.
Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
Shares of Colgate-Palmolive jumped over 6% as the consumer goods giant outlined a resilient growth plan through 2026, even after reporting a significant profit decline in a tough operating climate.
Norwegian Cruise Line Holdings (NCLH) reported robust annual revenue of $9.69 billion and net income of $663.5 million, reigniting investor interest. However, the stock's recent volatility and a significant one-year decline in total shareholder return have sparked a debate over whether the current share price accurately reflects the company's recovery trajectory and future prospects.
Dentsply Sirona faces mounting pressure as declining sales and poor capital returns challenge its recovery narrative. With shares down sharply over multiple years, investors question management's strategy in a competitive dental market.
While famously dismissing gold as a non-productive asset, Warren Buffett's historic silver investment reveals a preference for metals with tangible industrial utility—a distinction growing more relevant as silver deficits deepen amid soaring green-energy demand.
HMRC opens phone lines and boosts digital services on the final Saturday before the January 31 deadline, as over a million taxpayers missed the cut-off last year.
Galderma Group's (SWX:GALD) shares have faced significant pressure in recent months, contrasting sharply with its strong yearly performance. This analysis delves into whether the current valuation presents a genuine entry point or reflects deeper concerns about the dermatology giant's ambitious growth narrative.
The stablecoin issuer finished 2025 with over $10 billion in net profit, backed by a $17.4 billion gold reserve and a U.S. Treasury portfolio that rivals major nations, as demand for its USDT token continues to surge globally.
Kofi Ampadu, the partner who led a16z's Talent x Opportunity fund, has left the firm months after the program was paused indefinitely, signaling a potential retreat from structured DEI efforts in venture capital.
ExxonMobil's 2025 year-end results underscore a reshaped corporate strategy, delivering record shareholder returns and production milestones in Guyana and the Permian, while advancing carbon capture and enterprise digitalization.
Despite posting a quarterly loss in its core wood products unit amid 'extremely challenging' markets, Weyerhaeuser closed 2025 with strategic pivots. The forestry giant is doubling down on its land management and nascent 'Climate Solutions' business, while managing a disciplined capital return to shareholders.
WisdomTree Investments capped off a transformative 2025 with record assets under management, fueled by a landmark European expansion and a burgeoning digital assets platform. The firm's strategic acquisition of Ceres Partners has also opened a new frontier in private markets, setting the stage for continued margin growth in 2026.
D-Wave Quantum solidifies its dual-platform strategy with the acquisition of Quantum Circuits, announces multi-million dollar enterprise contracts, and relocates its headquarters from Silicon Valley to Florida, marking a significant shift in its operational and market focus.
Microchip Technology expands its embedded systems portfolio with the launch of the PIC32CM PL10 microcontroller family and an enhanced maXTouch M1 touchscreen line, targeting growing demand in automotive displays and industrial automation.
